People’s vaccine: Calls grow for equal access to coronavirus vaccine as rich countries hoard supply

While the United States, Britain and other wealthy countries race to vaccinate their populations against the coronavirus, a new report finds that as much as 90% of the population in dozens of poorer countries could be forced to wait until at least 2022 because wealthy countries are hoarding so much of the vaccine supply. A growing movement is calling for the development of a people’s vaccine and the suspension of intellectual property rights to expand access. We speak with Dr. Mohga Kamal-Yanni, a policy adviser to the People’s Vaccine Alliance, and Achal Prabhala, a public health advocate and coordinator of the AccessIBSA project, which campaigns for access to medicines in India, Brazil and South Africa